Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof

An autoimmune, ulinastatin technology, applied in the field of medicinal chemistry, can solve problems such as side effects infection, increased neuron loss, etc.

Active Publication Date: 2011-02-16
GUANGDONG TECHPOOL BIO-PHARMA CO LTD
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, MS drug therapy is mainly aimed at anti-inflammation and immune regulation. The standard classic treatment in the acute phase is high-dose hormone shock therapy, which is often accompanied by serious side effects such as infection, gonadal suppression, and tumors, and inhibits endogenous brain protection pathways. , increase neuron loss, so it is necessary to find safer and more effective therapeutic drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof
  • Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1 prepares ulinastatin dry powder injection

[0013] Take 100 million units of filtered sterilized ulinastatin aqueous solution, add 20 grams of mannitol to dissolve, adjust the pH to neutral, add water for injection to 2000 ml, add sodium chloride to adjust isotonicity, filter aseptically, and pack in 1000 pieces In a vial, freeze-dried under sterile conditions, to obtain.

Embodiment 2

[0014] Embodiment 2 prepares ulinastatin injection

[0015] Take 100 million units of filtered sterilized ulinastatin aqueous solution, add 20 grams of mannitol to dissolve, adjust the pH to neutral, add water for injection to 2000 ml, add sodium chloride to adjust isotonicity, filter aseptically, and pack 1000 pieces Get it in a vial.

Embodiment 3

[0016] Embodiment 3 Ulinastatin is to experimental autoimmune encephalomyelitis

[0017] Therapeutic effect of (experimental autoimmune encephalomyelitis, EAE) mice

[0018] Part 1: Establishment of EAE mouse model

[0019] Take 6-8 weeks old C57BL / 6 female mice, weighing (18-20) g, first prepare the following preparations:

[0020] Solution A: MOG35-55, 0.2 mg per mouse, dissolved in sterile endoin-free PBS.

[0021] Solution B: tuberculin H37RA, 0.4 mg per mouse, dissolved in complete Freund's adjuvant containing tuberculin H37RA.

[0022] Liquid A is emulsified in liquid B with an emulsifier for more than 30 minutes, and fully emulsified to make MOG emulsion.

[0023] After the mouse skin was disinfected, the emulsion was injected subcutaneously at multiple points in the lower abdomen on both sides. On day 0 and 48 hours, each mouse was injected with pertussis toxin, 0.4 μg (dissolved in 0.1 ml of PBS), and on day 7, an equal amount of MOG emulsion was subcutaneously in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an application of Ulinastatin in preparing a drug for curing autoimmune encephalomyelitis, and the drug related by the invention is derived from natural protein drugs purified by human urine, has stable and reliable quality and less adverse effects, and overcomes the defects of more side effects, influenced life quality of patients even caused death and the like existing in the common drugs such as glucocorticoid and the like for curing autoimmune encephalomyelitis. Contrastive studies of curative effects on animal models of the autoimmune encephalomyelitis find that Ulinastatin has the same curative effect as hormone.

Description

technical field [0001] The present invention relates to the field of medicinal chemistry. Specifically, the present invention relates to a medicine for treating autoimmune encephalomyelitis, and particularly relates to an application of ulinastatin as a medicine for treating autoimmune encephalomyelitis. Background technique [0002] Multiple sclerosis (Multiple Sclerosis, MS) is one of the most common neuroimmune diseases, and its prevalence is nearly three per thousand in temperate regions. Young people are prone to the disease, and the age of onset is about 28 years old; it has the characteristics of persistence, recurrence and gradual deterioration. 50% of patients need to walk with crutches 15 years after the first onset, and the fatality rate is high. Therefore, this disease is extremely harmful. Since the pathogenesis of MS is still unclear, there is no effective treatment. [0003] The pathology of MS includes inflammatory infiltration, demyelination and neurodege...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61P25/00A61K9/19A61K9/08A61K38/57A61P37/02
Inventor 傅和亮吴蓉蓉邹春芽陈颖华明娟
Owner GUANGDONG TECHPOOL BIO-PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap